Daiichi Sankyo Company, Limited

Stocks

4568

JP3475350009

Market Closed - Japan Exchange Other stock markets 12:00:00 21/07/2026 pm IST			5-day change	1st Jan Change
2,815.00 ^JPY	+0.86%		+4.59%	-15.92%

16/07	Noetra Corp. announced that it has received funding from a group of investors	CI
08/07	European Stocks Close Sharply Lower in Wednesday Trading; Oil Prices Spike as US-Iran War Reignites	MT

Transcript : Daiichi Sankyo Company, Limited - Special Call

Published on 06/04/2024 at 04:30 am IST

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Hiroyuki Okuzawa (Executives)

Hello colleagues. My name is Hiroyuki Okuzawa and I am the President and CEO of Daiichi Sankyo. Thank you for joining our briefing session focused on the

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Daiichi Sankyo Company, Limited

16/07	Noetra Corp. announced that it has received funding from a group of investors	CI
08/07	European Stocks Close Sharply Lower in Wednesday Trading; Oil Prices Spike as US-Iran War Reignites	MT
08/07	AstraZeneca and Daiichi near UK Enhertu price deal - Bloomberg	AN
08/07	UK Regulator in Talks with AstraZeneca, Daiichi Sankyo for Enhertu Pricing	MT
08/07	AstraZeneca, Daiichi Sankyo Near Deal With UK Regulator Over Enhertu Pricing	MT
08/07	AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports	RE
30/06	Trump's push for the world's lowest drug prices hits snag with mid-sized companies	RE
30/06	Daiichi Sankyo Board Approves Treasury Share Disposal Under Medium-Term Share Compensation Plan	MT
29/06	Gloomy mood in Europe as Wall Street pushes ahead
29/06	Stockholm stocks rebound, OMXS30 index rises 0.4%	FW
29/06	Steady gains on the Stockholm market after the morning rise, OMXS30 index up 0.3 percent	FW
29/06	Datroway Recommended for Approval in EU for TNBC	CI
29/06	Daiichi Sankyo and AstraZeneca Receive Approval for Enhertu as First Tumor Agnostic HER2 Directed Therapy in the EU	CI
29/06	AstraZeneca's Enhertu Gets EU Approval for HER2-Positive Solid Tumors	MT
29/06	AstraZeneca's Enhertu wins first EU tumour-agnostic approval for HER2	AN